Participants:18–64 years · 65+ years
Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide

Contact Research Centre

Myelofibrosis+2

Not recruiting

InvestigationalNo placebo

Continued Treatment Study for Patients with Myelofibrosis, Post-Lung Transplant BOS, or Chronic Graft-Versus-Host Disease Using Itacitinib

InvestigationalNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Itacitinib

Contact Research Centre

Acute kidney injury

Not recruiting

Registered drug

Study on Ravulizumab for Protecting Chronic Kidney Disease Patients from Acute Kidney Injury After Heart Surgery

Registered drug

Greece

Participants:18–64 years · 65+ years
Substances:Ravulizumab

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa

Investigational

Greece

Participants:18–64 years · 65+ years
Substances:Spesolimab

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Greece

Participants:18–64 years · 65+ years
Substances:Obefazimod

Contact Research Centre

Cardiac amyloidosis

Not recruiting

Registered drugNo placebo

Study on Long-Term Safety of Eplontersen for Adults with Transthyretin-Mediated Amyloid Cardiomyopathy

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Ascorbic Acid Bp

Contact Research Centre

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Not recruiting

Registered drugNo placebo

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Risankizumab

Contact Research Centre

Factor IX deficiency

Not recruiting

InvestigationalNo placebo

Study on the Efficacy and Safety of Fidanacogene Elaparvovec Gene Therapy in Adult Males with Moderate to Severe Hemophilia B

InvestigationalNo placebo

Greece

Participants:18–64 years
Substances:Fidanacogene Elaparvovec

Contact Research Centre

Haemophilia

Not recruiting

Registered drugNo placebo

Study on Fitusiran for Preventing Bleeding in Males Aged 12 and Older with Severe Hemophilia A or B, with or without Inhibitors

Registered drugNo placebo

Greece

Participants:0–17 years · 18–64 years · 65+ years
Substances:Fitusiran

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study Comparing Pembrolizumab and Lenvatinib with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Lenvatinib

Contact Research Centre

Find therapies in clinical trials near you – page 77

964 trials match your criteria

Breast cancer

Study Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment

Malignant melanoma

Study on Nivolumab for Preventing Melanoma Recurrence in Patients with Completely Removed Stage IIB/C Melanoma

Hidradenitis

Study on the Effectiveness and Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

Myelofibrosis+2

Continued Treatment Study for Patients with Myelofibrosis, Post-Lung Transplant BOS, or Chronic Graft-Versus-Host Disease Using Itacitinib

Acute kidney injury

Study on Ravulizumab for Protecting Chronic Kidney Disease Patients from Acute Kidney Injury After Heart Surgery

Hidradenitis

Study to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa

Colitis ulcerative

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Cardiac amyloidosis

Study on Long-Term Safety of Eplontersen for Adults with Transthyretin-Mediated Amyloid Cardiomyopathy

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Factor IX deficiency

Study on the Efficacy and Safety of Fidanacogene Elaparvovec Gene Therapy in Adult Males with Moderate to Severe Hemophilia B

Haemophilia

Study on Fitusiran for Preventing Bleeding in Males Aged 12 and Older with Severe Hemophilia A or B, with or without Inhibitors

Non-small cell lung cancer

Study Comparing Pembrolizumab and Lenvatinib with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.